139 related articles for article (PubMed ID: 24057448)
1. Serial three-dimensional optical coherence tomography assessment of strut coverage and intraluminal structures after drug-eluting stent implantation.
Maeda T; Okamura T; Yamada J; Nao T; Tateishi H; Yoshimura M; Oda T; Shiraishi K; Nakashima T; Nakamura T; Miura T; Yano M
Cardiovasc Interv Ther; 2014 Jan; 29(1):31-9. PubMed ID: 24057448
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
3. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
[TBL] [Abstract][Full Text] [Related]
5. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
[TBL] [Abstract][Full Text] [Related]
7. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
[TBL] [Abstract][Full Text] [Related]
8. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
9. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
Karjalainen P; Paana T; Ylitalo A; Sia J; Nammas W
Acta Radiol; 2017 Sep; 58(9):1077-1084. PubMed ID: 28273737
[TBL] [Abstract][Full Text] [Related]
11. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).
Attizzani GF; Bezerra HG; Ormiston J; Wang W; Donohoe D; Wijns W; Costa MA
Am J Cardiol; 2013 Nov; 112(10):1557-64. PubMed ID: 23992957
[TBL] [Abstract][Full Text] [Related]
12. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
13. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
[TBL] [Abstract][Full Text] [Related]
17. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
19. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
